HCWB - Total Utang marang Modal HCW Biologics
HCW Biologics Inc. (HCWB) relies on outsourcing protein synthesis and testing to maintain its status as a lean scientific team without excessive overhead. The company develops immune platforms targeting oncology and cellular senescence, protecting its innovations with patents. This chart of the asset's value with the 0.91 metric is available below, although intellectual property lawsuits and potential trial delays are weighing on the market capitalization.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_HCWB_-_HCW-Biologics-Inc._-_All-Debt-to-Shareholders-Equity-Ratio "HCWB (HCW Biologics) riwayat Total Utang marang Modal saka 04.07.2022 nganti 30.10.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan HCW Biologics Inc.
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas HCW Biologics Inc.|HCWB - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal HCW Biologics, Inc.|HCWB - Gunggung utang perusahaan|Utang marang nilai buku HCW Biologics|HCWB - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan HCW Biologics|Likuiditas cepet hcwbiologics.com
- informasi bathi lan kelipatan valuasi:
Analisis dhasar perusahaan:HCW Biologics Inc.
Market expectations for HCW Biologics Inc. (HCWB) depend on the balance between debt load and equity, where the total liabilities-to-equity ratio measures the degree of financial leverage. By analyzing the historical changes in the total debt-to-equity ratio, an investor can assess the company's resilience to early-stage development risks and its need for continuous external financing for this high-risk asset.
Analisis pesaing HCW Biologics Inc.
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|Pieris Pharmaceuticals Inc - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi SVRA (Savara Pharma)|RIGL: Total Utang marang Modal|Rasio Total Utang marang Ekuitas anaptysbio.com|Rasio Total Utang marang Ekuitas ATXS|Rasio Total Utang marang Ekuitas enGene Holdings Inc (ENGN)|Rasio Total Utang marang Ekuitas RAPT (RAPT Therapeutics, Inc.)|JBIO (aerovatetx.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ACRS (Aclaris Therapeutics)|kyvernatx.com - Utang marang Ekuitas|Tiziana Life Sciences Ltd - Total Utang marang Modal|Koefisien Total Utang marang Modal Cabaletta Bio Inc. CABA|Ventyx Bio (VTYX) - Utang marang Ekuitas|Utang marang Modal Theratechnologies, Inc (THTX)|Utang marang Ekuitas Avalo Therapeutics, Inc|Utang marang Ekuitas ELDN|Utang marang Ekuitas Agenus Inc. (AGEN)|CLYM - Utang marang Modal|Total Utang marang Modal ZURA (Zura Bio Limited)|Rasio Utang marang Modal aTyr Pharmaceuticals|Adagene Corp - Total Utang marang Modal|Koefisien Total Utang marang Modal ImageneBio Inc IMA|STTK: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Equillium|Utang marang Ekuitas Connect Biopharma Holdings|Immunic Inc (IMUX) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas ATRA (Atara Biotherapeutics)|IFRX (inflarx.de) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal XFOR (X4 Pharmaceuticals, Inc.)|Koefisien Total Utang marang Modal Adicet Bio Inc. (ACET)|CELU - Utang marang Ekuitas|INMB (INmune Bio Corporation) - Rasio Utang marang Ekuitas|BRNS: Total Utang marang Modal|Rasio Total Utang marang Ekuitas kezarlifesciences.com|Rasio Total Utang marang Ekuitas SABS|Akari Therapeutics PLC (AKTX) - Koefisien Total Utang marang Modal|Total Utang marang Modal ENLV|QTTB (q32bio.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal GOVX (GeoVax Labs, Inc.)|EDSA - Rasio Total Utang marang Ekuitas|IBIO: Rasio Total Utang marang Ekuitas|Carisma Therapeutics (CARM) - Rasio Total Utang marang Ekuitas|XTLB: Total Utang marang Modal|BOLT (Bolt Biotherapeutics, Inc.) - Utang marang Ekuitas|Utang marang Ekuitas Aptevo Therapeutics, Inc.|AIM ImmunoTech, Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ADTX|GRI (GRI Bio Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal XRTX (XORTX)|Total Utang marang Modal Vyome Therapeutics HIND|REVB - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi INDP (indaptusrx.com)|Scinai Immunotherapeutics Ltd. (SCNI) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas CalciMedica|AFMD (Affimed NV) - Total Utang marang Modal|Total Utang marang Modal Allakos Therapeutics|Rasio Total Utang marang Ekuitas HOOK (HOOKIPA Pharma Inc.)|IGMS (igmbio.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ITOS (iTeos Therapeutics, Inc.)|Koefisien Total Utang marang Modal Ocean Biomedical Inc (OCEA)|TCBP - Utang marang Ekuitas|Third Harmonic Bio Inc (THRD) - Rasio Total Utang marang Ekuitas